📣 VC round data is live. Check it out!
- Public Comps
- Brainscan
Brainscan Valuation Multiples
Discover revenue and EBITDA valuation multiples for Brainscan and similar public comparables like Genetic Analysis, Prostatype Genomics, Spermosens, Cykel AI and more.
Brainscan Overview
About Brainscan
Brainscan SA is an AI system for lesion detection in the human brain based on computed tomography images. Algorithms powered by artificial intelligence analyze CT brain scans, automatically detecting and highlighting potential pathological changes.
Founded
2017
HQ

Employees
N/A
Website
Sectors
Financials (FY)
EV
$5M
Valuation Multiples
Start free trialBrainscan Financials
Brainscan reported last fiscal year revenue of $118K and negative EBITDA of ($759K).
In the same fiscal year, Brainscan generated $113K in gross profit, ($759K) in EBITDA losses, and had net loss of ($779K).
Brainscan P&L
In the most recent fiscal year, Brainscan reported revenue of $118K and EBITDA of ($759K).
Brainscan is unprofitable as of last fiscal year, with gross margin of 96%, EBITDA margin of (644%), and net margin of (661%).
Financial data powered by Morningstar, Inc.
Brainscan Stock Performance
Brainscan has current market cap of $5M, and enterprise value of $5M.
Market Cap Evolution
Brainscan's stock price is $4.06.
Brainscan share price decreased by 4.0% in the last 30 days, and by 50.4% in the last year.
Brainscan has an EPS (earnings per share) of $-0.61.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $5M | $5M | -4.0% | -4.0% | -40.6% | -50.4% | $-0.61 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialBrainscan Valuation Multiples
Brainscan trades at 38.2x EV/Revenue multiple, and (5.9x) EV/EBITDA.
Brainscan Financial Valuation Multiples
As of May 8, 2026, Brainscan has market cap of $5M and EV of $5M.
Brainscan has a P/E ratio of (6.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Brainscan Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


Brainscan Margins & Growth Rates
In the most recent fiscal year, Brainscan reported gross margin of 96%, EBITDA margin of (644%), and net margin of (661%).
Brainscan Margins
Brainscan Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
Brainscan Operational KPIs
Data powered by FactSet, Inc. and Morningstar, Inc.
Brainscan Competitors
Brainscan competitors include Genetic Analysis, Prostatype Genomics, Spermosens, Cykel AI, Elite Diagnostic, Level Bio, Attana, GenIP, Unith and Genomed.
Most Brainscan public comparables operate across Medical Imaging & Diagnostics, Artificial Intelligence, HealthTech, B2B SaaS, Horizontal SaaS, Generative AI and Longevity.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1.6x | 1.4x | (4.6x) | (4.9x) | |||
| 56.8x | — | (0.8x) | — | |||
| — | — | (3.4x) | — | |||
| — | — | — | — | |||
| — | — | — | — | |||
| 0.6x | — | (14.8x) | — | |||
| 7.2x | — | (2.0x) | — | |||
| 6.7x | — | (1.0x) | — | |||
This data is available for Pro users. Sign up to see all Brainscan competitors and their valuation data. Start Free Trial | ||||||
Brainscan Funding History
Before going public, Brainscan raised $2M in total equity funding, across 4 rounds.
Last private valuation of Brainscan was $2M, after raising $300K in April 2019 from LSI (Life Science Innovations Fund).
Brainscan Funding Rounds
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Brainscan
| When was Brainscan founded? | Brainscan was founded in 2017. |
| Where is Brainscan headquartered? | Brainscan is headquartered in Poland. |
| Is Brainscan publicly listed? | Yes, Brainscan is a public company listed on Warsaw Stock Exchange. |
| What is the stock symbol of Brainscan? | Brainscan trades under BSN ticker. |
| When did Brainscan go public? | Brainscan went public in 2024. |
| Who are competitors of Brainscan? | Brainscan main competitors include Genetic Analysis, Prostatype Genomics, Spermosens, Cykel AI, Elite Diagnostic, Level Bio, Attana, GenIP, Unith, Genomed. |
| What is the current market cap of Brainscan? | Brainscan's current market cap is $5M. |
| What is the current revenue of Brainscan? | Brainscan's last fiscal year revenue is $118K. |
| What is the current EV/Revenue multiple of Brainscan? | Current revenue multiple of Brainscan is 38.2x. |
| Is Brainscan profitable? | No, Brainscan is not profitable. |
| How many companies Brainscan has acquired to date? | Brainscan hasn't acquired any companies yet (or none have been disclosed publicly). |
| In how many companies Brainscan has invested to date? | Brainscan hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to Brainscan
Lists including Brainscan
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.